Evidence map›Paper›PMID 31500319›Full record

ArticleMetabolites2019

Pharmacometabolomics of Bronchodilator Response in Asthma and the Role of Age-Metabolite Interactions.

Rachel S Kelly, Joanne E Sordillo, Sharon M Lutz, Lydiana Avila, Manuel Soto-Quiros, Juan C Celedón, Michael J McGeachie, Amber Dahlin, Kelan Tantisira, Mengna Huang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Pharmacogenetics of childhood uncontrolled asthma.Expert review of clinical immunology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Application of Metabolomics across the Spectrum of Pulmonary and Critical Care Medicine.American journal of respiratory cell and molecular biology · 2024
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Pharmacometabolomics of Asthma as a Road Map to Precision Medicine.Handbook of experimental pharmacology · 2023
    Article
  12. Article
  13. Article
  14. Pharmacogenetics of Bronchodilator Response: Future Directions.Current allergy and asthma reports · 2021
    Review
  15. Review
  16. Precision Medicine in Childhood Asthma: Omic Studies of Treatment Response.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Rachel S KellyChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. hprke@channing.harvard.edu.ORCID 0000-0003-3023-1822
Joanne E SordilloPRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA. joanne_sordillo@harvardpilgrim.org.
Sharon M LutzPRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA. sharon.m.lutz@gmail.com.
Lydiana AvilaDepartment of Pediatrics, Hospital Nacional de Niños, 10101 San José, Costa Rica. lydiana98@gmail.com.
Manuel Soto-QuirosDepartment of Pediatrics, Hospital Nacional de Niños, 10101 San José, Costa Rica. msotoqui34@yahoo.com.
Juan C CeledónDivision of Pediatric Pulmonary Medicine, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA 15224, USA. juan.celedon@chp.edu.
Michael J McGeachieChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. remmg@channing.harvard.edu.
Amber DahlinChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. readh@channing.harvard.edu.
Kelan TantisiraChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. rekgt@channing.harvard.edu.
Mengna HuangChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. remhu@channing.harvard.edu.ORCID 0000-0002-4626-4816
Clary B ClishThe Broad Institute, Cambridge, MA 02142, USA. clary@broadinstitute.org.
Scott T WeissChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. restw@channing.harvard.edu.
Jessica Lasky-SuChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. rejas@channing.harvard.edu.
Ann Chen WuPRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA. Ann.Wu@childrens.harvard.edu.ORCID 0000-0003-0599-9063
Brigham and Women's Hospital · USHarvard University · USHospital Nacional de Niños · CRBroad Institute · USUniversity of Pittsburgh · US

Funding

Systems Biology of Airway DiseaseP01HL132825 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMEO, DAWN L · 2016 to 2020
$12.6M
Integrative Metabolomics of Asthma SeverityR01HL123915 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2014 to 2023
$7.0M
Asthma Exacerbations and MicroRNA prediction: Treatment Response in an Underserved Ethnicity (AEM-TRUE)R01HL139634 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MCGEACHIE, MICHAEL JOHN · 2018 to 2022
$4.3M
Mechanistic insights into asthma pathogenesis through the integration of asthma genes, risk exposures, and metabolomicsR01HL141826 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2018 to 2021
$3.4M
Age-Dependent Pharmacogenomics of Asthma Treatment (ADAPT)R01HD085993 · NICHD · HARVARD PILGRIM HEALTH CARE, INC. · PI WU, ANN CHEN · 2016 to 2020
$3.1M
Multi-Omic Endotyping of AsthmaK01HL146980 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KELLY, RACHEL SABINE · 2019 to 2023
$891k
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthmaK01HL130629 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DAHLIN, AMBER · 2016 to 2020
$818k
Common Genetic Pathways Underlying CVD and COPDK01HL125858 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LUTZ, SHARON MARIE · 2015 to 2019
$721k
Foundation for the National Institutes of Health HL04370Foundation for the National Institutes of Health HL066289Foundation for the National Institutes of Health HL132825National Institute of Child Health and Human Development R01HD085993NHLBI NIH HHS 1R01HL123915-01NHLBI NIH HHS 1R01HL141826-0NHLBI NIH HHS 5R01HL123915-05NHLBI NIH HHS K01 HL125858NHLBI NIH HHS K01HL125858NHLBI NIH HHS K01 HL130629NHLBI NIH HHS K01 HL146980NHLBI NIH HHS K01HL146980-01NHLBI NIH HHS P01 HL132825NHLBI NIH HHS R01 HL123915NHLBI NIH HHS R01 HL139634NHLBI NIH HHS R01 HL141826NIH HHS HL117191NIH HHS HL119952U.S. Department of Defense W81XWH-17-1-0533
6 · The paper itself

Abstract

The role of metabolism in modifying age-related differential responses to asthma medications is insufficiently understood. The objective of this study was to determine the role of the metabolome in modifying the effect of age on bronchodilator response (BDR) in individuals with asthma. We used longitudinal measures of BDR and plasma metabolomic profiling in 565 children with asthma from the Childhood Asthma Management Program (CAMP) to identify age by metabolite interactions on BDR. The mean ages at the three studied time-points across 16 years of follow-up in CAMP were 8.8, 12.8, and 16.8 years; the mean BDRs were 11%, 9% and 8%, respectively. Of 501 identified metabolites, 39 (7.8%) demonstrated a significant interaction with age on BDR (

Indexed as

age by metabolite interactionasthmabronchodilator responsechildhood asthma management programcholesterol estersGABAgenetic epidemiology of asthma in Costa Ricametabolomicspharmacometabolomics

Identifiers

PMID31500319
PMCPMC6780678
OpenAlexW2971740795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.